The Characteristics of Compound Heterozygosity for Hemoglobin G-Makassar with Hb E in Malaysia

References

• George E. Thalassaemia Carrier Diagnosis in Malaysia. Thalassaemia Diagnostic Service; 1998.
   Google Scholar
• Orkin SH, Kazazian HH. The mutation and polymorphism of the human β-globin gene and its surrounding DNA. Ann Rev Gene. 1984;18(1):131–171. doi:10.1146/annurev.ge.18.120184.001023
   PubMed Web of Science ®Google Scholar
• Mary Anne Tan JA, Chin PS, Wong YC, Tan KL, Chan LL, George E. Characterisation and confirmation of rare beta‐thalassaemia mutations in the Malay, Chinese and Indian ethnic groups in Malaysia. Pathology. 2006;38(5):437–441. doi:10.1080/00313020600922538
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia: molecular biology and clinical medicine. Hemoglobin. 1997;21(4):299–319. doi:10.3109/03630269709000664
   PubMed Web of Science ®Google Scholar
• Weatherall D. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res. 2011;134(4):493.
   PubMedGoogle Scholar
• Alwi ZB, Syed-Hassan S-NR-K. Thalassemia in Malaysia. Hemoglobin. 2022;46(1):45–52. doi:10.1080/03630269.2022.2057326
   PubMed Web of Science ®Google Scholar
• Mohamad AS, Hamzah R, Selvaratnam V, Yegapan S, Sathar J. Human hemoglobin G-Makassar variant masquerading as sickle cell anemia. Hematol Rep. 2018;10(3):7210. doi:10.4081/hr.2018.7210
   PubMedGoogle Scholar
• Viprakasit V, Wiriyasateinkul A, Sattayasevana B, Miles KL, Laosombat V. Hb G-makassar [β 6 (A3) Glu→ Ala; codon 6 (GAG→ GCG)]: molecular characterization, clinical, and hematological effects. Hemoglobin. 2002;26(3):245–253. doi:10.1081/HEM-120015028
   PubMed Web of Science ®Google Scholar
• Blackwell RQ, Oemijati S, Pribadi W, Weng M-I, Liu C-S. Hemoglobin G Makassar: β6 Glu→ Ala. Biochimica Et Biophysica Acta (BBA)-Protein Structure. 1970;214(3):396–401. doi:10.1016/0005-2795(70)90297-7
   PubMedGoogle Scholar
• Sangkitporn S, Mitrakul C, Rerkamnuaychoke B, Sutivigit Y, Sangkitporn S. Hb G Makassar (beta 6: glu→ ala) in a Thai family. J Med Assoc Thai. 2002;85(5):577–582.
   PubMedGoogle Scholar
• Adachi K, Kim J, Konitzer P, Asakura T, Saviola B, Surrey S. Effects of β6 amino acid hydrophobicity on stability and solubility of hemoglobin tetramers. FEBS Lett. 1993;315(1):47–50. doi:10.1016/0014-5793(93)81130-R
   PubMed Web of Science ®Google Scholar
• Pagnier J, Bihoreau M, Baudin V, Edelstein S, Poyart C. Polymerization and solubility of recombinant hemoglobins alpha 2 beta 2 6 Glu--> Ala (Hb Makassar) and alpha 2 beta 2 6 Glu--> Ala, 23 Val--> Ile. Comptes Rendus de L’academie des sciences Serie III, Sciences de la vie. 1993;316(4):431–436.
   PubMed Web of Science ®Google Scholar
• Benz EJ, Berman BW, Tonkonow BL, et al. Molecular analysis of the beta-thalassemia phenotype associated with inheritance of hemoglobin E (alpha 2 beta2(26)Glu leads to Lys). J Clin Invest. 1981;68(1):118–126. doi:10.1172/JCI110226
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Winichagoon P. Clinical and hematologic aspects of hemoglobin E β-thalassemia. Current Opinion Hematol. 2000;7(2):106–112. doi:10.1097/00062752-200003000-00006
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin. 1987;11(1):65–88. doi:10.3109/03630268709036587
   PubMed Web of Science ®Google Scholar
• Tyagi S, Pati H, Choudhry V, Saxena R. Clinico-haematological profile of HbE syndrome in adults and children. Hematology. 2004;9(1):57–60. doi:10.1080/10245330310001638983
   PubMedGoogle Scholar
• Mishra P, Pati H, Chatterjee T, et al. Hb SE disease: a clinico-hematological profile. Ann Hematol. 2005;84(10):667–670. doi:10.1007/s00277-005-1044-2
   PubMed Web of Science ®Google Scholar
• Hanafi SB, Abdullah WZ, Adnan RA, et al. Genotype-phenotype association of HbE/β-thalassemia disease and the role of genetic modifiers. Malays J Paediatr Child Health. 2016;22:1–16.
   Google Scholar
• Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011;134(4):522.
   PubMedGoogle Scholar
• Ibrahim HM, Muda Z, Othman IS, et al. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry. BMJ open. 2020;10(6):e037974. doi:10.1136/bmjopen-2020-037974
   PubMed Web of Science ®Google Scholar
• Vichinsky E. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program. 2007;2007(1):79–83. doi:10.1182/asheducation-2007.1.79
   Google Scholar
• Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007;49(3):329–332. doi:10.1002/pbc.21275
   PubMed Web of Science ®Google Scholar
• Morris CR, Kuypers FA, Kato GJ, et al. Hemolysis‐associated pulmonary hypertension in thalassemia. Ann NY Acad Sci. 2005;1054(1):481–485. doi:10.1196/annals.1345.058
   PubMedGoogle Scholar
• Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99(1):36–43. doi:10.1182/blood.V99.1.36
   PubMed Web of Science ®Google Scholar
• Atichartakarn V, Chuncharunee S, Chandanamattha P, Likittanasombat K, Aryurachai K. Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/β-thalassemia patient. Blood. 2004;103(7):2844–2846. doi:10.1182/blood-2003-09-3094
   PubMed Web of Science ®Google Scholar
• Sanchaisuriya K, Chirakul S, Srivorakun H, et al. Effective screening for double heterozygosity of Hb E/α0-thalassemia. Ann Hematol. 2008;87(11):911–914. doi:10.1007/s00277-008-0520-x
   PubMed Web of Science ®Google Scholar
• Charoenkwan P, Wanapirak C, Thanarattanakorn P, et al. Hemoglobin E levels in double heterozygotes of hemoglobin E and SEA-type alpha-thalassemia. Southeast Asian J Trop Med Public Health. 2005;36(2):467–470.
   PubMedGoogle Scholar
• Pornprasert S, Tookjai M, Punyamung M, Pongpunyayuen P. HbE Level and Red Cell Parameters in Heterozygous HbE With and Without α0-Thalassemia Trait. Indian J Hematol Blood Transfusion. 2018;34(4):662–665. doi:10.1007/s12288-018-0947-8
   PubMed Web of Science ®Google Scholar
• Alauddin H, Khirotdin RA, Ithnin Z, et al. HbA2 levels in normal,[Beta]-thalassaemia and haemoglobin E carriers by capillary electrophoresis. Malays J Pathol. 2012;34(2):161.
   PubMedGoogle Scholar
• Chu SH, Ortega M, Feliciano P, et al. Conversion of HbS to Hb G-makassar by adenine base editing is compatible with normal hemoglobin function. Blood. 2021;138(Supplement 1):951. doi:10.1182/blood-2021-150922
   Google Scholar
• Chu SH, Packer MS, Olins JR, et al. A novel base editing approach to directly edit the causative mutation in sickle cell disease. Mol Ther. 2020;28:808.
   Web of Science ®Google Scholar
• Newby GA, Yen JS, Woodard KJ, et al. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature. 2021;595(7866):295–302. doi:10.1038/s41586-021-03609-w
   PubMed Web of Science ®Google Scholar